Androgen receptor modulators |
|---|
| ARTooltip Androgen receptor | | Agonists | |
|---|
| SARMsTooltip Selective androgen receptor modulator |
- Nonsteroidal: 198RL26
- ACP-105
- AC-262,536
- Acetothiolutamide
- Acetoxolutamide
- Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)
- BMS-564,929
- DTIB
- Enobosarm (ostarine, MK-2866, GTx-024, S-22)
- FTBU-1
- GLPG-0492
- GSK2881078
- GSK-4336A
- GSK-8698
- LG121071 (LGD-121071)
- LGD-2226
- LGD-2941 (LGD-122941)
- LGD-3303
- LGD-4033
- LY305
- JNJ-26146900
- JNJ-28330835
- JNJ-37654032
- OPK-88004 (LY-2452473, TT-701)
- ORM-11984
- PF-06260414
- R-1
- RU-59063
- S-1
- S-23
- S-40503
- S-101479
- Vosilasarm
- Steroidal: EM-9017
- MK-0773
- S42
- TFM-4AS-1
- YK-11
|
|---|
| Antagonists |
- Steroidal: 7α-Thioprogesterone
- 7α-Thiospironolactone
- 7α-Thiomethylspironolactone
- 11α-Hydroxyprogesterone
- 15β-Hydroxycyproterone acetate
- Abiraterone
- Abiraterone acetate
- Allyltestosterone
- Benorterone
- BOMT
- Canrenoic acid
- Canrenone
- Chlormadinone acetate
- Clascoterone
- Clometerone
- Cyproheptadine
- Cyproterone
- Cyproterone acetate
- Delanterone
- Delmadinone acetate
- Dicirenone
- Dienogest
- Drospirenone
- DU-41165
- Edogestrone
- EM-4350
- EM-5854
- EM-5855
- EM-6537
- Epitestosterone
- Galeterone
- Guggulsterone
- Ludaterone
- Medrogestone
- Megestrol acetate
- Mespirenone
- Metogest
- Mexrenone
- Mifepristone
- Nomegestrol acetate
- Nordinone
- Osaterone
- Osaterone acetate
- Oxendolone
- Potassium canrenoate
- Promegestone
- Prorenone
- Rosterolone
- RU-15328
- SC-5233 (spirolactone)
- Spironolactone
- Spirorenone
- Spiroxasone
- Topterone
- Trimegestone
- Trimethyltrienolone (R-2956)
- Zanoterone
|
|---|
|
|---|
| GPRC6A | |
|---|
- See also
- Receptor/signaling modulators
- Androgens and antiandrogens
- Estrogen receptor modulators
- Progesterone receptor modulators
- List of androgens and anabolic steroids
|
Estrogen receptor modulators |
|---|
| ERTooltip Estrogen receptor | | Agonists |
- Steroidal: 2-Hydroxyestradiol
- 2-Hydroxyestrone
- 3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol
- 3α-Androstanediol
- 3α,5α-Dihydrolevonorgestrel
- 3β,5α-Dihydrolevonorgestrel
- 3α-Hydroxytibolone
- 3β-Hydroxytibolone
- 3β-Androstanediol
- 4-Androstenediol
- 4-Androstenedione
- 4-Fluoroestradiol
- 4-Hydroxyestradiol
- 4-Hydroxyestrone
- 4-Methoxyestradiol
- 4-Methoxyestrone
- 5-Androstenediol
- 7-Oxo-DHEA
- 7α-Hydroxy-DHEA
- 7α-Methylestradiol
- 7β-Hydroxyepiandrosterone
- 8,9-Dehydroestradiol
- 8,9-Dehydroestrone
- 8β-VE2
- 10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)
- 11β-Chloromethylestradiol
- 11β-Methoxyestradiol
- 15α-Hydroxyestradiol
- 16-Ketoestradiol
- 16-Ketoestrone
- 16α-Fluoroestradiol
- 16α-Hydroxy-DHEA
- 16α-Hydroxyestrone
- 16α-Iodoestradiol
- 16α-LE2
- 16β-Hydroxyestrone
- 16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)
- 17α-Estradiol (alfatradiol)
- 17α-Dihydroequilenin
- 17α-Dihydroequilin
- 17α-Epiestriol (16α-hydroxy-17α-estradiol)
- 17α-Ethynyl-3α-androstanediol
- 17α-Ethynyl-3β-androstanediol
- 17β-Dihydroequilenin
- 17β-Dihydroequilin
- 17β-Methyl-17α-dihydroequilenin
- Abiraterone
- Abiraterone acetate
- Alestramustine
- Almestrone
- Anabolic steroids (e.g., testosterone and esters, methyltestosterone, metandienone (methandrostenolone), nandrolone and esters, many others; via estrogenic metabolites)
- Atrimustine
- Bolandiol
- Bolandiol dipropionate
- Butolame
- Clomestrone
- Cloxestradiol
- Conjugated estriol
- Conjugated estrogens
- Cyclodiol
- Cyclotriol
- DHEA
- DHEA-S
- ent-Estradiol
- Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)
- Epimestrol
- Equilenin
- Equilin
- ERA-63 (ORG-37663)
- Esterified estrogens
- Estetrol
- Estradiol
- Estradiol esters
- Lipoidal estradiol
- Polyestradiol phosphate
- Estramustine
- Estramustine phosphate
- Estrapronicate
- Estrazinol
- Estriol
- Estriol esters
- Polyestriol phosphate
- Estrofurate
- Estrogenic substances
- Estromustine
- Estrone
- Estrone esters
- Estrone methyl ether
- Estropipate
- Etamestrol (eptamestrol)
- Ethinylandrostenediol
- Ethinylestradiol
- Ethinylestradiol 3-benzoate
- Ethinylestradiol sulfonate
- Ethinylestriol
- Ethylestradiol
- Etynodiol
- Etynodiol diacetate
- Hexolame
- Hippulin
- Hydroxyestrone diacetate
- Lynestrenol
- Lynestrenol phenylpropionate
- Mestranol
- Methylestradiol
- Moxestrol
- Mytatrienediol
- Nilestriol
- Norethisterone
- Noretynodrel
- Orestrate
- Pentolame
- Prodiame
- Prolame
- Promestriene
- RU-16117
- Quinestradol
- Quinestrol
- Tibolone
- Nonsteroidal: (R,R)-THC
- (S,S)-THC
- 2,8-DHHHC
- β-LGND1
- β-LGND2 (GTx-878)
- AC-186
- Allenestrol
- Allenolic acid
- Benzestrol
- Bifluranol
- Bisdehydrodoisynolic acid
- Butestrol
- Carbestrol
- D-15414
- DCW234
- Diarylpropionitrile
- Dienestrol
- Diethylstilbestrol
- Diethylstilbestrol esters
- Dimestrol (dianisylhexene)
- Dimethylstilbestrol
- Doisynoestrol (fenocycline)
- Doisynolic acid
- Efavirenz
- Elacestrant
- ERB-196 (WAY-202196)
- Erteberel (SERBA-1, LY-500307)
- Estrobin (DBE)
- Fenestrel
- FERb 033
- Fosfestrol (diethylstilbestrol diphosphate)
- Furostilbestrol (diethylstilbestrol difuroate)
- GTx-758
- Hexestrol
- ICI-85966 (Stilbostat)
- M2613
- meso-Butestrol
- meso-Hexestrol
- Mestilbol
- Methallenestril
- Methestrol
- Methestrol dipropionate
- Paroxypropione
- Pentafluranol
- Phenestrol
- Prinaberel (ERB-041, WAY-202041)
- Propylpyrazoletriol
- Quadrosilan
- SC-3296
- SC-4289
- SERBA-2
- SKF-82,958
- Terfluranol
- Triphenylbromoethylene
- Triphenylchloroethylene
- Triphenyliodoethylene
- Triphenylmethylethylene (triphenylpropene)
- WAY-166818
- WAY-169916
- WAY-200070
- WAY-204688 (SIM-688)
- WAY-214156
- Unknown/unsorted: ERB-26
- ERA-45
- ERB-79
- ZK-283197
- Xenoestrogens: Anise-related (e.g., anethole, anol, dianethole, dianol, photoanethole)
- Chalconoids (e.g., isoliquiritigenin, phloretin, phlorizin (phloridzin), wedelolactone)
- Coumestans (e.g., coumestrol, psoralidin)
- Flavonoids (incl. 7,8-DHF, 8-prenylnaringenin, apigenin, baicalein, baicalin, biochanin A, calycosin, catechin, daidzein, daidzin, ECG, EGCG, epicatechin, equol, formononetin, glabrene, glabridin, genistein, genistin, glycitein, kaempferol, liquiritigenin, mirificin, myricetin, naringenin, penduletin, pinocembrin, prunetin, puerarin, quercetin, tectoridin, tectorigenin)
- Lavender oil
- Lignans (e.g., enterodiol, enterolactone, nyasol (cis-hinokiresinol))
- Metalloestrogens (e.g., cadmium)
- Pesticides (e.g., alternariol, dieldrin, endosulfan, fenarimol, HPTE, methiocarb, methoxychlor, triclocarban, triclosan)
- Phytosteroids (e.g., digitoxin (digitalis), diosgenin, guggulsterone)
- Phytosterols (e.g., β-sitosterol, campesterol, stigmasterol)
- Resorcylic acid lactones (e.g., zearalanone, α-zearalenol, β-zearalenol, zearalenone, zeranol (α-zearalanol), taleranol (teranol, β-zearalanol))
- Steroid-like (e.g., deoxymiroestrol, miroestrol)
- Stilbenoids (e.g., resveratrol, rhaponticin)
- Synthetic xenoestrogens (e.g., alkylphenols, bisphenols (e.g., BPA, BPF, BPS), DDT, parabens, PBBs, PHBA, phthalates, PCBs)
- Others (e.g., agnuside, rotundifuran)
|
|---|
Mixed (SERMsTooltip Selective estrogen receptor modulators) |
- 2-Phenylbenzofuran
- 2-Phenyl-1-benzothiophene
- 4'-Hydroxynorendoxifen
- 27-Hydroxycholesterol
- Acefluranol
- Acolbifene
- Afimoxifene
- Anordiol
- Anordrin
- Arzoxifene
- Bazedoxifene
- Brilanestrant
- Broparestrol
- Camizestrant
- Chlorotrianisene
- Clomifene
- Clomifenoxide
- CN-55945-27
- Cyclofenil
- D-15413
- Desmethylchlorotrianisene
- Droloxifene
- Enclomifene
- Endoxifen
- Etacstil (GW-5638, DPC-974)
- Ethamoxytriphetol (MER-25)
- Femarelle
- Fispemifene
- GW-7604
- ICI-55548
- Idoxifene
- Lasofoxifene
- Levormeloxifene
- LN-1643
- LN-2299
- LY-117018
- Menerba
- Miproxifene
- Miproxifene phosphate
- MRL-37
- Nafoxidine
- Nitromifene
- NNC 45-0095
- NNC 45-0320
- NNC 45-0781
- NNC 45-1506
- Ormeloxifene
- Ospemifene
- Panomifene
- Pipendoxifene
- Promensil
- Raloxifene
- Rimostil (P-081)
- Spironolactone
- SS1010
- Tamoxifen
- TAS-108 (SR-16234)
- Toremifene
- Trioxifene
- TZE-5323
- U-11555A
- U-11634
- Y-134
- Zindoxifene
- Zuclomifene
|
|---|
| Antagonists |
- (R,R)-THC
- 7β-Hydroxy-DHEA
- Chloroindazole
- Cytestrol acetate
- EM-800 (SCH-57050)
- Epitiostanol
- ERA-90
- ERB-88
- Fulvestrant (ICI-182780)
- Glyceollins (I, II, III, IV)
- ICI-164384
- MDL-101906
- Mepitiostane
- Methylepitiostanol
- Methylpiperidinopyrazole
- MIBE
- Oxabicycloheptene sulfonate
- Phenytoin
- PHTPP
- Prochloraz
- RU-39411
- RU-58668
- SS1020
- TAS-108 (SR-16234)
- ZB716
- ZK-164015
- ZK-191703
- Coregulator-binding modulators: ERX-11
|
|---|
|
|---|
| GPERTooltip G protein-coupled estrogen receptor | | Agonists | |
|---|
| Antagonists | |
|---|
| Unknown | |
|---|
|
|---|
- See also
- Receptor/signaling modulators
- Estrogens and antiestrogens
- Androgen receptor modulators
- Progesterone receptor modulators
- List of estrogens
|
|
|---|
| Ionotropic | | GABAATooltip γ-Aminobutyric acid A receptor |
- Positive modulators (abridged; see here for a full list): α-EMTBL
- Alcohols (e.g., drinking alcohol, 2M2B)
- Anabolic steroids
- Avermectins (e.g., ivermectin)
- Barbiturates (e.g., phenobarbital)
- Benzodiazepines (e.g., diazepam)
- Bromide compounds (e.g., potassium bromide)
- Carbamates (e.g., meprobamate)
- Carbamazepine
- Chloralose
- Chlormezanone
- Clomethiazole
- Dihydroergolines (e.g., ergoloid (dihydroergotoxine))
- Etazepine
- Etifoxine
- Fenamates (e.g., mefenamic acid)
- Flavonoids (e.g., apigenin, hispidulin)
- Fluoxetine
- Flupirtine
- Imidazoles (e.g., etomidate)
- Kava constituents (e.g., kavain)
- Lanthanum
- Loreclezole
- Monastrol
- Neuroactive steroids (e.g., allopregnanolone, cholesterol, THDOC)
- Niacin
- Niacinamide
- Nonbenzodiazepines (e.g., β-carbolines (e.g., abecarnil), cyclopyrrolones (e.g., zopiclone), imidazopyridines (e.g., zolpidem), pyrazolopyrimidines (e.g., zaleplon))
- Norfluoxetine
- Petrichloral
- Phenols (e.g., propofol)
- Phenytoin
- Piperidinediones (e.g., glutethimide)
- Propanidid
- Pyrazolopyridines (e.g., etazolate)
- Quinazolinones (e.g., methaqualone)
- Retigabine (ezogabine)
- ROD-188
- Skullcap constituents (e.g., baicalin)
- Stiripentol
- Sulfonylalkanes (e.g., sulfonmethane (sulfonal))
- Topiramate
- Valerian constituents (e.g., valerenic acid)
- Volatiles/gases (e.g., chloral hydrate, chloroform, diethyl ether, paraldehyde, sevoflurane)
- Antagonists: Bicuculline
- Coriamyrtin
- Dihydrosecurinine
- Famiraprinium
- Gabazine (SR-95531)
- Hydrastine
- Hyenanchin (mellitoxin)
- Iso-THIP
- PHP-501
- Pitrazepin
- Securinine
- Sinomenine
- SR-42641
- THAZ
- Thio-4-PIOL
- Thio-THIP
- Thiocolchicoside
- Tutin
- Negative modulators: 1,3M1B
- 3M2B
- 11-Ketoprogesterone
- 17-Phenylandrostenol
- α3IA
- α5IA (LS-193,268)
- β-CCB
- β-CCE
- β-CCM
- β-CCP
- β-EMGBL
- Anabolic steroids
- Amiloride
- Anisatin
- β-Lactams (e.g., penicillins, cephalosporins, carbapenems)
- Basmisanil
- Bemegride
- Bicyclic phosphates (TBPS, TBPO, IPTBO)
- BIDN
- Bilobalide
- Bupleurotoxin
- Bupropion
- CHEB
- Chlorophenylsilatrane
- Cicutoxin
- Cloflubicyne
- Cyclothiazide
- DHEA
- DHEA-S
- Dieldrin
- (+)-DMBB
- DMCM
- DMPC
- EBOB
- Etbicyphat
- FG-7142 (ZK-31906)
- Fiproles (e.g., fipronil)
- Flavonoids (e.g., amentoflavone, oroxylin A)
- Flumazenil
- Fluoroquinolones (e.g., ciprofloxacin)
- Flurothyl
- Furosemide
- Golexanolone
- Iomazenil (123I)
- IPTBO
- Isopregnanolone (sepranolone)
- L-655,708
- Laudanosine
- Lindane
- MaxiPost
- Morphine
- Morphine-3-glucuronide
- MRK-016
- Naloxone
- Naltrexone
- Nicardipine
- Nonsteroidal antiandrogens (e.g., apalutamide, bicalutamide, enzalutamide, flutamide, nilutamide)
- Oenanthotoxin
- Pentylenetetrazol (pentetrazol)
- Phenylsilatrane
- Picrotoxin (i.e., picrotin, picrotoxinin and dihydropicrotoxinin)
- PNV-001
- Pregnenolone sulfate
- Propybicyphat
- PWZ-029
- Radequinil
- Ro 15-4513
- Ro 19-4603
- RO4882224
- RO4938581
- Sarmazenil
- SCS
- Suritozole
- TB-21007
- TBOB
- TBPS
- TCS-1105
- Terbequinil
- TETS
- Thujone
- U-93631
- Zinc
- ZK-93426
|
|---|
| GABAA-ρTooltip γ-Aminobutyric acid A-rho receptor |
- Antagonists: (S)-2-MeGABA
- (S)-4-ACPBPA
- (S)-4-ACPCA
- 2-MeTACA
- 3-APMPA
- 4-ACPAM
- 4-GBA
- cis-3-ACPBPA
- Aza-THIP
- CGP-36742 (SGS-742)
- DAVA
- Gabazine (SR-95531)
- Gaboxadol (THIP)
- I4AA
- Iso-THIP
- Isonipecotic acid
- Loreclezole
- P4MPA
- P4S
- SKF-97541
- SR-95318
- SR-95813
- THAZ
- Thio-THIP
- TPMPA
- trans-3-ACPBPA
- ZAPA
|
|---|
|
|---|
| Metabotropic | | GABABTooltip γ-Aminobutyric acid B receptor |
- Positive modulators: ADX-71441
- ASP-8062
- BHF-177
- BHFF
- rac-BHFF
- BSPP
- CGP-7930
- CGP-13501
- GS-39783
- INDV-1000
- KK-92A
- Antagonists: 2-Hydroxysaclofen
- CGP-35348
- CGP-36742
- CGP-46381
- CGP-52432
- CGP-54626
- CGP-55845
- CGP-64213
- DAVA
- Homotaurine (tramiprosate, 3-APS)
- Phaclofen
- Saclofen
- SCH-50911
- Negative modulators: Compound 14
|
|---|
|
|---|
- See also
- Receptor/signaling modulators
- GABAA receptor positive modulators
- GABA metabolism/transport modulators
|
Glutamate receptor modulators |
|---|
Ionotropic glutamate receptor modulators |
|---|
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor | |
|---|
| KARTooltip Kainate receptor | |
|---|
| NMDARTooltip N-Methyl-D-aspartate receptor |
- Unsorted: Allosteric modulators: AGN-241751
|
|---|
- See also: Receptor/signaling modulators
- Metabotropic glutamate receptor modulators
- Glutamate metabolism/transport modulators
|
Metabotropic glutamate receptor modulators |
|---|
| Group I | | mGluR1Tooltip Metabotropic glutamate receptor 1 |
- Antagonists: BAY 36-7620
- CPCCOEt
- Cyclothiazide
- LY-367,385
- LY-456,236
- MCPG
- NPS-2390
|
|---|
| mGluR5Tooltip Metabotropic glutamate receptor 5 |
- Antagonists: CTEP
- DMeOB
- LY-344,545
- Mavoglurant
- MCPG
- NPS-2390
- Remeglurant
- SIB-1757
- SIB-1893; Negative allosteric modulators: AZD9272
- Basimglurant
- Dipraglurant
- Fenobam
- GRN-529
- MPEP
- MTEP
- Raseglurant
|
|---|
|
|---|
| Group II | | mGluR2Tooltip Metabotropic glutamate receptor 2 |
- Agonists: BINA
- CBiPES
- DCG-IV
- Eglumetad (LY-354740)
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-487,379
- LY-566,332
- MGS-0028
- Pomaglumetad (LY-404039)
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad (LY-544344); Positive allosteric modulators: JNJ-40411813 (ADX-71149)
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039
- PCCG-4; Negative allosteric modulators: Decoglurant
- RO4491533
|
|---|
| mGluR3Tooltip Metabotropic glutamate receptor 3 |
- Agonists: CBiPES
- DCG-IV
- Eglumetad (LY-354740)
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-487,379
- MGS-0028
- Pomaglumetad (LY-404039)
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad (LY-544344)
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039; Negative allosteric modulators: Decoglurant
- RO4491533
|
|---|
|
|---|
| Group III | | mGluR4Tooltip Metabotropic glutamate receptor 4 |
- Agonists: Glutamate
- L-AP4
- LSP2-9166
- PHCCC
- VU-001,171
- VU-0155,041; Positive allosteric modulators: Foliglurax
- MPEP
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR6Tooltip Metabotropic glutamate receptor 6 |
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR7Tooltip Metabotropic glutamate receptor 7 |
- Antagonists: CPPG
- MAP4
- MMPIP
- MPPG
- MSOP
- MTPG
- UBP-1112
- XAP044; Negative allosteric modulators: ADX71743
|
|---|
| mGluR8Tooltip Metabotropic glutamate receptor 8 |
- Agonists: DCPG
- Glutamate
- L-AP4; Positive allosteric modulators: AZ12216052
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
|
|---|
See also: Receptor/signaling modulators • Ionotropic glutamate receptor modulators • Glutamate metabolism/transport modulators |
|
Growth factor receptor modulators |
|---|
| Angiopoietin |
- Agonists: Angiopoietin 1
- Angiopoietin 4
- Antagonists: Angiopoietin 2
- Angiopoietin 3
- Kinase inhibitors: Altiratinib
- CE-245677
- Rebastinib
- Antibodies: Evinacumab (against angiopoietin 3)
- Nesvacumab (against angiopoietin 2)
|
|---|
| CNTF |
- Agonists: Axokine
- CNTF
- Dapiclermin
|
|---|
| EGF (ErbB) | EGF (ErbB1/HER1) |
- Agonists: Amphiregulin
- Betacellulin
- EGF (urogastrone)
- Epigen
- Epiregulin
- Heparin-binding EGF-like growth factor (HB-EGF)
- Murodermin
- Nepidermin
- Transforming growth factor alpha (TGFα)
- Kinase inhibitors: Afatinib
- Agerafenib
- Brigatinib
- Canertinib
- Dacomitinib
- Erlotinib
- Gefitinib
- Grandinin
- Icotinib
- Lapatinib
- Neratinib
- Osimertinib
- Vandetanib
- WHI-P 154
- Antibodies: Cetuximab
- Depatuxizumab
- Depatuxizumab mafodotin
- Futuximab
- Imgatuzumab
- Matuzumab
- Necitumumab
- Nimotuzumab
- Panitumumab
- Zalutumumab
|
|---|
| ErbB2/HER2 |
- Antibodies: Ertumaxomab
- Pertuzumab
- Trastuzumab
- Trastuzumab deruxtecan
- Trastuzumab duocarmazine
- Trastuzumab emtansine
- Kinase inhibitors: Afatinib
- Lapatinib
- Mubritinib
- Neratinib
- Tucatinib
|
|---|
| ErbB3/HER3 |
- Agonists: Neuregulins (heregulins) (1, 2, 6 (neuroglycan C))
- Antibodies: Duligotumab
- Patritumab
- Seribantumab
|
|---|
| ErbB4/HER4 |
- Agonists: Betacellulin
- Epigen
- Heparin-binding EGF-like growth factor (HB-EGF)
- Neuregulins (heregulins) (1, 2, 3, 4, 5 (tomoregulin, TMEFF))
|
|---|
|
|---|
| FGF | | FGFR1 |
- Agonists: Ersofermin
- FGF (1, 2 (bFGF), 3, 4, 5, 6, 8, 10 (KGF2), 20)
- Repifermin
- Selpercatinib
- Trafermin
- Velafermin
|
|---|
| FGFR2 |
- Agonists: Ersofermin
- FGF (1, 2 (bFGF), 3, 4, 5, 6, 7 (KGF), 8, 9, 10 (KGF2), 17, 18, 22)
- Palifermin
- Repifermin
- Selpercatinib
- Sprifermin
- Trafermin
- Antibodies: Aprutumab
- Aprutumab ixadotin
- Kinase inhibitors: Infigratinib
|
|---|
| FGFR3 |
- Agonists: Ersofermin
- FGF (1, 2 (bFGF), 4, 8, 9, 18, 23)
- Selpercatinib
- Sprifermin
- Trafermin
- Antibodies: Burosumab (against FGF23)
|
|---|
| FGFR4 |
- Agonists: Ersofermin
- FGF (1, 2 (bFGF), 4, 6, 8, 9, 19)
- Trafermin
|
|---|
| Unsorted | |
|---|
|
|---|
| HGF (c-Met) |
- Agonists: Fosgonimeton
- Hepatocyte growth factor
- Potentiators: Dihexa (PNB-0408)
- Kinase inhibitors: Altiratinib
- AM7
- AMG-458
- Amuvatinib
- BMS-777607
- Cabozantinib
- Capmatinib
- Crizotinib
- Foretinib
- Golvatinib
- INCB28060
- JNJ-38877605
- K252a
- MK-2461
- PF-04217903
- PF-2341066
- PHA-665752
- SU-11274
- Tivantinib
- Volitinib
- Antibodies: Emibetuzumab
- Ficlatuzumab
- Flanvotumab
- Onartuzumab
- Rilotumumab
- Telisotuzumab
- Telisotuzumab vedotin
|
|---|
| IGF | | IGF-1 |
- Agonists: des(1-3)IGF-1
- Insulin-like growth factor-1 (somatomedin C)
- IGF-1 LR3
- Insulin-like growth factor-2 (somatomedin A)
- Insulin
- Mecasermin
- Mecasermin rinfabate
- Kinase inhibitors: BMS-754807
- Linsitinib
- NVP-ADW742
- NVP-AEW541
- OSl-906
- Antibodies: AVE-1642
- Cixutumumab
- Dalotuzumab
- Figitumumab
- Ganitumab
- Robatumumab
- R1507
- Teprotumumab
- Xentuzumab (against IGF-1 and IGF-2)
|
|---|
| IGF-2 |
- Agonists: Insulin-like growth factor-2 (somatomedin A)
- Antibodies: Dusigitumab
- Xentuzumab (against IGF-1 and IGF-2)
|
|---|
| Others |
- Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7)
- Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
- Trofinetide
|
|---|
|
|---|
| LNGF (p75NTR) |
- Agonists: BDNF
- BNN-20
- BNN-27
- Cenegermin
- DHEA
- DHEA-S
- NGF
- NT-3
- NT-4
- Antibodies: Against NGF: ABT-110 (PG110)
- ASP-6294
- Fasinumab
- Frunevetmab
- Fulranumab
- MEDI-578
- Ranevetmab
- Tanezumab
- Aptamers: Against NGF: RBM-004
- Decoy receptors: LEVI-04 (p75NTR-Fc)
|
|---|
| PDGF |
- Agonists: Becaplermin
- Platelet-derived growth factor (A, B, C, D)
- Kinase inhibitors: Agerafenib
- Avapritinib
- Axitinib
- Crenolanib
- Imatinib
- Lenvatinib
- Masitinib
- Motesanib
- Nintedanib
- Pazopanib
- Radotinib
- Quizartinib
- Ripretinib
- Sunitinib
- Sorafenib
- Toceranib
- Antibodies: Olaratumab
- Ramucirumab
- Tovetumab
|
|---|
| RET (GFL) | | GFRα1 |
- Agonists: Glial cell line-derived neurotrophic factor (GDNF)
- Liatermin
- Kinase inhibitors: Vandetanib
|
|---|
| GFRα2 |
- Agonists: Neurturin (NRTN)
- Kinase inhibitors: Vandetanib
|
|---|
| GFRα3 |
- Kinase inhibitors: Vandetanib
|
|---|
| GFRα4 |
- Agonists: Persephin (PSPN)
- Kinase inhibitors: Vandetanib
|
|---|
| Unsorted |
- Kinase inhibitors: Agerafenib
|
|---|
|
|---|
| SCF (c-Kit) |
- Agonists: Ancestim
- Stem cell factor
|
|---|
| TGFβ | |
|---|
| Trk | | TrkA |
- Positive allosteric modulators: ACD856
- ACD857
- Ponazuril (ACD855)
- Toltrazuril
- Negative allosteric modulators: VM-902A
- Kinase inhibitors: Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib
- GZ-389988
- K252a
- Larotrectinib
- Lestaurtinib
- Milciclib
- ONO-4474
- ONO-5390556
- PLX-7486
- Rebastinib
- SNA-120 (pegylated K252a))
- Antibodies: Against TrkA: GBR-900; Against NGF: ABT-110 (PG110)
- ASP-6294
- Fasinumab
- Frunevetmab
- Fulranumab
- MEDI-578
- Ranevetmab
- Tanezumab
- Aptamers: Against NGF: RBM-004
- Decoy receptors: ReN-1820 (TrkAd5)
|
|---|
| TrkB |
- Agonists: 3,7-DHF
- 3,7,8,2'-THF
- 4'-DMA-7,8-DHF
- 7,3'-DHF
- 7,8-DHF
- 7,8,2'-THF
- 7,8,3'-THF
- Amitriptyline
- Braegen-02
- BDNF
- BNN-20
- Deoxygedunin
- Diosmetin
- DMAQ-B1
- HIOC
- LM22A-4
- N-Acetylserotonin
- NT-3
- NT-4
- Norwogonin (5,7,8-THF)
- R7
- R13 (BrAD-R13, Braegen-01)
- TDP6
- Antagonists: ANA-12
- Cyclotraxin B
- Gossypetin (3,5,7,8,3',4'-HHF)
- Positive allosteric modulators: ACD856
- ACD857
- Ponazuril (ACD855)
- Toltrazuril
- Kinase inhibitors: Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib
- GZ-389988
- K252a
- Larotrectinib
- Lestaurtinib
- ONO-4474
- ONO-5390556
- PLX-7486
|
|---|
| TrkC |
- Agonists: BNN-20
- DHEA
- NT-3
- Positive allosteric modulators: ACD856
- Kinase inhibitors: Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib
- GZ-389988
- K252a
- Larotrectinib
- Lestaurtinib
- ONO-4474
- ONO-5390556
- PLX-7486
|
|---|
|
|---|
| VEGF |
- Agonists: Placental growth factor (PGF)
- Ripretinib
- Telbermin
- VEGF (A, B, C, D (FIGF))
- Allosteric modulators: Cyclotraxin B
- Kinase inhibitors: Agerafenib
- Altiratinib
- Axitinib
- Cabozantinib
- Cediranib
- Fruquintinib
- Lapatinib
- Lenvatinib
- Motesanib
- Nintedanib
- Pazopanib
- Pegaptanib
- Rebastinib
- Regorafenib
- Semaxanib
- Sorafenib
- Sunitinib
- Toceranib
- Tivozanib
- Vandetanib
- WHI-P 154
- Antibodies: Alacizumab pegol
- Bevacizumab
- Icrucumab
- Ramucirumab
- Ranibizumab
- Decoy receptors: Aflibercept
|
|---|
| Others |
- Additional growth factors: Adrenomedullin
- Colony-stimulating factors (see here instead)
- Connective tissue growth factor (CTGF)
- Ephrins (A1, A2, A3, A4, A5, B1, B2, B3)
- Erythropoietin (see here instead)
- Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF)
- Glia maturation factor (GMF)
- Hepatoma-derived growth factor (HDGF)
- Interleukins/T-cell growth factors (see here instead)
- Leukemia inhibitory factor (LIF)
- Macrophage-stimulating protein (MSP; HLP, HGFLP)
- Midkine (NEGF2)
- Migration-stimulating factor (MSF; PRG4)
- Oncomodulin
- Pituitary adenylate cyclase-activating peptide (PACAP)
- Pleiotrophin
- Renalase
- Thrombopoietin (see here instead)
- Wnt signaling proteins
- Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)
|
|---|
Sigma receptor modulators |
|---|
| σ1 |
- Allosteric modulators: Phenytoin; Positive: Methylphenylpiracetam
- SOMCL-668
|
|---|
| σ2 |
- Antagonists: AC-927
- BD-1008
- BD-1067
- CM-156
- LR-172
- MIN-101
- Panamesine (EMD-57455)
- SAS-0132
- Zervimesine (CT-1812)
- Unknown/unsorted: 3-Methoxydextrallorphan
- 3-MeO-PCE
- 4-MeO-PCP
- 5-MeO-DALT
- 5-MeO-DiPT
- Clemastine
- DiPTTooltip N,N-Diisopropyltryptamine
- DPTTooltip N,N-Dipropyltryptamine
- Ibogaine
- Lu 29-252
- Nemonapride
- Nepinalone
- Noribogaine
- Pentazocine
- RS-67,333
- Safinamide
- TMATooltip 3,4,5-Trimethoxyamphetamine
- UMB-23
- UMB-82
- W-18
|
|---|
| Unsorted |
- Antagonists: AHD1
- AZ66
- Lamotrigine
- Naloxone
- SM-21
- UMB-100
- UMB-101
- UMB-103
- UMB-116
- YZ-011
- YZ-069
- YZ-185
- Allosteric modulators: SKF-83959
|
|---|
See also: Receptor/signaling modulators |
Xenobiotic-sensing receptor modulators |
|---|
| CARTooltip Constitutive androstane receptor | |
|---|
| PXRTooltip Pregnane X receptor | |
|---|
- See also
- Receptor/signaling modulators
|
|